Pediatrix Medical Group, Inc. (MD)
(Delayed Data from NYSE)
$10.56 USD
-0.31 (-2.85%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $10.56 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
MD 10.56 -0.31(-2.85%)
Will MD be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for MD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MD
Pediatrix Medical Up 45.8% in 3 Months: Is it Too Late to Jump In?
Pediatrix Medical Group (MD)'s Technical Outlook is Bright After Key Golden Cross
MD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Is Pediatrix Medical Group (MD) Up 9.5% Since Last Earnings Report?
Pediatrix Medical Group (MD) Shows Fast-paced Momentum But Is Still a Bargain Stock
MD or RVTY: Which Is the Better Value Stock Right Now?
Other News for MD
Insider Sale: CEO James Swift Sells Shares of Pediatrix Medical Group Inc (MD)
Midland and SOQUEM Identify on Nachicapau New High-Grade Mineralized Occurrences and Expand the Footprint of the Copper-Gold-Silver Hydrothermal System
Key Takeaways From Pediatrix Medical Group Analyst Ratings
Pediatrix Medical price target raised by $2 at Truist, here's why
Insider Sale at Pediatrix Medical Group Inc (MD)